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rediction for Unprotected Left Main Stenting
hao-Liang Chen, MD,* Jack P. Chen, MD,# Gary Mintz, MD,** Bo Xu, MBBS,†
ing Kan, MD,* Fei Ye, MD,* Junjie Zhang, MD,* Xuewen Sun, MD,‡ Yawei Xu, MD,
ing Jiang, MD,¶ Aiping Zhang, MD,§ Gregg W. Stone, MD**
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bjectives This study aimed to compare the NERS (New Risk Stratiﬁcation) and SYNTAX (Synergy
etween Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) scores for prognosti-
ation after stenting of unprotected left main stenosis in a ”real-world” setting.
ackground In contrast to existing systems, the NERS score encompasses clinical, procedural, and
ngiographic characteristics.
ethods The NERS score was derived from 260 patients with unprotected left main stenosis who
nderwent percutaneous coronary intervention and tested in 337 patients in a consecutive left main
egistry (66.55  10.49 years, 78.9% men) undergoing percutaneous coronary intervention in a pro-
pective, multicenter trial. Six-month clinical and angiographic follow-up was obtained in 100% and
8.9% of patients, respectively. The primary end point was major adverse cardiac events (MACE),
ncompassing myocardial infarction, all-cause death, and target vessel revascularization. Receiver-
perator characteristic (ROC) curve was generated for the comparison of NERS versus SYNTAX
cores.
esults The NERS score consisted of 54 variables (17 clinical, 4 procedural, and 33 angiographic). A
ERS score 25 demonstrated a sensitivity and speciﬁcity of 92.0% and 74.1% (MACE as state vari-
ble), respectively, signiﬁcantly higher than SYNTAX intermediate risk (20.5% and 25.4%) or SYNTAX
igher risk (70.5% and 35.2%, p for all 0.001). At follow-up, myocardial infarction, cardiac death,
nd target vessel revascularization occurred in 3.0%, 5.6%, and 13.1% of patients, respectively, for a
omposite MACE of 26.0%. A NERS score 25 (hazard ratio: 1.13; 95% conﬁdence interval [CI]: 1.11
o 1.16; p  0.001) was the only independent predictor of cumulative MACE and stent thrombosis
t follow-up (odds ratio: 31.04; 95% CI: 19.36 to 67.07; p  0.001).
onclusions The NERS score was more predictive of MACE than the SYNTAX score was. Further
tudy is needed to address their relative roles in assessment for appropriateness of coronary artery
ypass graft versus percutaneous coronary intervention for unprotected left main coronary artery
tenosis. (J Am Coll Cardiol Intv 2010;3:632–41) © 2010 by the American College of Cardiology
oundation
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633ercutaneous coronary intervention (PCI) of unprotected left
ain coronary artery (ULMCA) stenosis remains controversial
uring the drug-eluting stent (DES) era (1,2), with coronary
rtery bypass graft (CABG) surgery remaining the gold stan-
ard in many parts of the world. Although the presence of left
ain (LM) stenosis influences the complexity of PCI (3–7),
linical comorbidities likely also contribute to post-CABG
linical outcomes (8–13). Although pre-treatment assessments
ith the European system for cardiac operative risk evaluation
EuroSCORE) and Parsonnet score (12,13) are widely advo-
ated, their complex calculation and exclusion of procedural or
esion characteristics potentially limit their applicability in
veryday practice.
See page 642
Furthermore, the SYNTAX (Synergy between Percutane-
us Coronary Intervention with Taxus and Cardiac Surgery)
core (14) for prediction of clinical events after CABG or PCI
n UPLMS does not comprehensively incorporate clinical
ariables. Thus, the potential contributions of clinical, proce-
ural, and angiographic indices in this patient cohort have not
een fully elucidated. We hereby compare a novel scoring
ystem, the NERS (New Risk Stratification) score, with the
YNTAX score in patients undergoing PCI for UPLMS.
ethods
tudy design and patient population. The NERS prospec-
ive registry involved UPLMS PCI from 4 centers in China
rom January 21, 1999, through March 1, 2009. Prior to
ebruary 2004, only bare-metal stents (BMS) were avail-
ble, and implantation of DES commenced subsequently.
he study protocol was approved by the Ethics Committee
f each participating center by November 18, 1998.
The decision on revascularization strategy for each pa-
ient with UPLMS was jointly formulated by cardiologists
nd cardiac surgeons, based upon clinical and angiographic
eatures. The UPLMS patients undergoing stent implanta-
ion were consecutively enrolled, and all data were entered
nto a dedicated database.
ariables for the SYNTAX and NERS scoring systems. The
YNTAX score was generated and classified as lower
0 to 22), intermediate (23 to 32), higher (33), and
igh-risk (23) scores. By September 29, 2006, 260
PLMS patients were analyzed and reported in the DIS-
AL (Drug-Eluting Stent for the Treatment of Left Main
isease) study (4), from which 126 variables were selected
nd analyzed by logistic regression. Probability score for
ach variable was then calculated. Variables with p value
0.05 were considered significant predictors and prospec-
ively evaluated in the present study. The NERS scoring
ystem, derived from these 260 UPLMS patients, consisted
f 54 variables that are defined and listed in Tables 1 and 2. sf these, double-stent techniques (4) were subdivided into
lassical crush, culotte, double kissing (DK) crush, T, and
/simultaneous kissing stent (SKS). Predicted scores for
verall and each double-stent technique were then
alculated.
Patients (n  260) in the DISTAL study were excluded
rom the present study. All clinical variables were recorded
y a follow-up team and reviewed/adjudicated by an inde-
endent committee. Scoring of angiographic and procedural
ariables was performed by 2 technicians from China
ardiovascular Research Foundation (Beijing, China), who
ere blinded to the present study.
In the NERS scoring system,
cores for the coronary artery
ree were numerically recorded
s 10. Angiographic variables in-
luded chronic total occlusion
CTO), true bifurcation, long
esion, proximal vessel 2.0
m, severe calcification, tortu-
us, and thrombotic. Left main
esions were classified by ostial,
ody, distal, and whole stem.
ccording to the criterion of
eaman et al. (15), the right
oronary artery supplies 16%,
nd the LM supplies 84% (66%
y left anterior descending artery
nd 34% by left circumflex ar-
ery) of the myocardium in right
ominance. Conversely, for left
ominance, the right coronary
rtery is not scored. For ostial
nd shaft or distal LM stenosis,
he highest score for distal LM
esion was considered the final
core for the LM. Similarly, tan-
em stenoses within 1 vessel,
uch as CTO with bifurcation,
ere scored as the highest score
f any lesion (i.e., CTO).
nd points. The primary end
oint was the rate of major adverse cardiac events (MACE),
efined as all-cause mortality, myocardial infarction (MI),
r target vessel revascularization (TVR) at follow-up. Stent
hrombosis (ST) was assessed as a secondary event.
rocedural and periprocedural medications. After written
nformed consent, all interventional procedures were per-
ormed according to current standard guidelines. Decisions
egarding glycoprotein IIb/IIIa inhibitors, low molecular-
eight heparin, stent type, pre-dilation, and intravascular
ltrasound were at operator’s discretion. All patients were
dvised to take aspirin (100 mg daily) lifelong. Prior to or
Abbreviations
and Acronyms
AUC  area under the curve
BMS  bare-metal stent(s)
CABG  coronary artery
bypass graft
CTO  chronic total
occlusion
DES  drug-eluting stent(s)
DK  double kissing
LM  left main
MACE  major adverse
cardiac events
MI  myocardial infarction
PCI  percutaneous
coronary intervention
QCA  quantitative coronary
angiography
ROC  receiver-operator
characteristic
SKS  simultaneous kissing
stent(s)
ST  stent thrombosis
TVR  target vessel
revascularization
ULMCA  unprotected left
main coronary artery
VD  vessel diseaseubsequent to January 2004, respective thienopyridine ther-
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634pies consisted of 3 months of ticlopidine (250 mg, twice
aily for 1 month, then 250 mg/day for 2 months) or 12
onths of clopidogrel (75 mg/day).
eﬁnitions. UPLMS was defined as flow-limiting LM
esion(s) in the absence of a patent bypass conduit to the left
ystem. Lesion variables, including isolated UPLMS dis-
ase, UPLMS with 1- to 3-vessel disease (VD), bifurcation
r trifurcation lesions, CTO, severe calcification, severe
ortuosity, thrombus, dominance, lesion number, and dis-
ased vessel number, were classified according to SYNTAX
Table 1. Clinical and Procedural Variables Contributed to
NERS Scoring System
Variables Definition(s) Score
Age 70 yrs Plus 1 score per 5-year increment 1.5
Sex Female 0.1
Serum creatinine 2.0 mg/dl, plus 1 score per
1.0 mg/dl increment
1.0
LV dysfunction LVEF 40%, plus 1 score per
10% reduction
1.5
Peripheral arterial disease 50% stenosis in diameter 1.5
Previous MI MI 14 days 5.5
AMI AMI within 14 days 7.3
Cardiomyocyte biomarkers* TNI/TNT at least 1 time more than
normal limit
2.5
Diabetes mellitus Diagnostic diabetes 1.8
Cardiogenic shock By AHA/ACC criteria 5.6
Needing IABP Before or during procedure 4.9
Hypertension Blood pressure 160/90 mm Hg
at admission
1.2
Smoker Including quitting 3 months 1.2
Stroke Within 6 months 0.5
Not taking statin Without taking statin 2 weeks 0.5
LDL 5.2 mmol/l 1.8
Gastrointestinal bleeding Within 6 months 0.2
Incomplete revascularization Right dominance: RCA/LAD 4.2,
LCX 0.5
Left dominance: LAD 5.1; LCX 3.3
Non-left main CTO failure CTO in RCA (right dominance), LAD,
and LCX
10.2
Without IVUS guidance IVUS not used to guide the PCI
procedure
0.5
2-stent technique 2-stent technique used for distal
left main stenosis
3.5
Classical crush stenting See Tamburino et al. (7) 3.3
DK crush stenting See Tamburino et al. (7) 0.02
Culotte See Wisniewska-Szmyt et al. (8) 2.1
T stenting See Wisniewska-Szmyt et al. (8) 0.6
V or SKS stenting See Wisniewska-Szmyt et al. (8) 2.6
*The biomarkers indicate prior-procedure plasma level.
ACC  American College of Cardiology; AHA  American Heart Association; AMI  acute
myocardial infarction; CTO  chronic total occlusion; DK  double kissing; IABP  intra-aortic
balloon pumping; IVUS intravascular ultrasound; LAD left anterior descending artery; LCX
left circumflex artery; LDL low-density lipoprotein; LV left ventricular; LVEF left ventricular
eject fraction; MI  myocardial infarction; NERS  New Risk Stratification; PCI  percutaneous
coronary intervention; RCA right coronary artery; SKS simultaneous kissing stenting; TNI
troponin I; TNT troponin T.14) definitions. Lesion classifications in the LM, down-tream lesion, restenosis in the LM, complete revascular-
zation, stent number, stent length, and stent diameter were
alculated based on the DISTAL criteria (4).
Double-stent technique for distal UPLMS was defined as
ither intention-to-treat or intraprocedural crossover from a
ingle-stent technique. All deaths were considered cardiac
nless a noncardiac cause was established clinically or at
utopsy. Myocardial infarction was diagnosed as plasma
evel of creatine kinase-myocardial band3 times the upper
ormal limit. In-stent restenosis was defined as 50%
iameter stenosis at follow-up; TVR was considered as
epeat PCI or CABG involving the index vessel. Stent
Table 2. Angiographic Variables Contributed to NERS Scoring System
Variables Right Dominance Left Dominance
RCA
CTO 1.0 0
True bifurcation 1.0 0
Long lesion 0.5 0
Proximal vessel 2.0 mm 0.5 0
Severe calciﬁcation 0.5 0
Tortuous 0.5 0
Thrombus-containing 1.0 0
LAD
CTO 3.5 5.8
True bifurcation 3.5 5.8
Long lesion 1.8 2.9
Proximal vessel 2.0 mm 1.8 2.9
Severe calciﬁcation 1.8 2.9
Tortuous 1.8 2.9
Thrombus-containing 3.5 5.8
LCX
CTO 1.8 4.2
True bifurcation 1.8 4.2
Long lesion 1.0 2.1
Proximal vessel 2.0 mm 1.0 2.1
Severe calciﬁcation 1.0 2.1
Tortuous 1.0 2.1
Thrombus-containing 1.8 4.2
LMT
Distal nonbifurcation 2.4 5.9
Distal true bifurcation 5.3 10.0
Distal trifurcation 5.3 10.0
CTO 5.3 10.0
Severe calciﬁcation 4.6 7.3
Whole stem 2.4 5.9
Ostial 1.6 3.5
Body 1.2 2.1
Thrombus-containing 5.3 10.0
No collateral from RCA 3.5 0.5
Restenotic lesions In-stent restenosis within LMT 6.4
Multivessel diseases Including downstream lesions and
diseased RCA
5.3LMT left main trunk; other abbreviations as in Table 1.
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635hrombosis was classified according to Academic Research
onsortium definitions as definite, probable, or possible;
nd as early (0 to 30 days), late (31 to 360 days), or very late
360 days) (16). Angiographic success was defined as
esidual stenosis 10% with TIMI (Thrombolysis In Myo-
ardial Infarction) flow grade 3 in both branches. Procedural
uccess referred to angiographic success in the absence of
n-hospital MACE.
linical follow-up. Phone interviews were conducted
onthly for 12 months and at 6-month intervals thereafter;
linical assessment was performed for suspected ischemic
ymptomatology. Clinical events were adjudicated by an
ndependent committee from 3 nonparticipating institu-
ions; all interventionalists and committee members had free
ccess to the database.
uantitative coronary angiographic analyses. Repeat an-
iography at 6 months after index procedure was scheduled
nless clinically indicated earlier. Quantitative coronary
ngiographic (QCA) analysis at baseline, post-stenting, and
t follow-up were performed by China Cardiovascular
esearch Foundation using edge detection techniques
CAAS II, version 5.0, Pie Medical, Maastricht, the Neth-
rlands). Binary restenosis was defined as luminal diameter
tenosis 50%; angiographic measurements included the
tented segment as well as margins 5 mm proximal and
istal to stent edge.
tatistical analysis. Continuous variables were expressed as
ean  SD and were compared using Student t test.
ategorical variables were presented as counts and percent-
ges and were compared using chi-square or Fisher exact
est. Survival curves were generated by the Kaplan-Meier
ethod, and survival among groups was compared using the
og-rank test. Cox proportional hazards models were used to
ssess risk factors for adverse events. Multivariable analysis,
ith all significant variables (defined as p 0.05 for the
ssociation), was performed to adjust for possible confound-
rs and to identify independent predictors of adverse events.
ensitivity, specificity, false-positive and false-negative,
nd positive and negative predictive values were calcu-
ated and analyzed by crosstable after weighted cases.
eceiver-operator characteristic (ROC) curves for NERS
nd SYNTAX scores were generated; area under the
urve (AUC) for each scoring method and end point was
ompared to the null hypothesis true area ( 0.5), with
orting out of 1-specificity, sensitivity, 95% confidence
nterval (CI), and significance. The value corresponding to
he highest accuracy (i.e., minimal false-negative and false-
ositive rates) was chosen as the optimal cutoff value. To
estify the difference of AUC and standard error from ROC
urve between 2 scoring systems by Delong, Delong
ethod, all variables, including cumulative MACE, stent
hrombosis, TVR for left main, MI, and cardiac death, were
ntered into Analyse-it (Analyse-it Software, Ltd., Hearnecientific Software Pty Ltd., Melbourne, Australia). A
value 0.05 was considered statistically significant. All
tatistical tests were 2-tailed. Statistical analysis was per-
ormed using SPSS version 16.0 (SPSS Inc., Chicago,
llinois).
esults
aseline clinical characteristics. From January 21, 1999, to
arch 1, 2009, of 854 patients with UPLMS, 517 (260
ormed the basis of DISTAL study, 257 underwent CABG)
ere excluded. The remaining 337 patients (age 66.58 
0.69 years, 78.9% men) treated by stent implantation were
tudied (Table 3). Sixty-four patients (19.0%) had decreased
eft ventricular ejection fraction (40%), and emergency
M stenting was needed in 22 patients (6.5%).
aseline angiographic and procedural characteristics. LM-
TO lesions were rare (2.1%); however, 23.1% had non–
M-CTO lesions (Table 4). Most UPLMS (83.7%) were
istal, with requirement of double-stent techniques in
22 (36.2%), including 41 DK crush (33.6%), 32 classical
rush (26.2%), 21 culotte (17.2%), 20 T (16.4%), and 8
/SKS (6.6%). Downstream lesions were seen in most
atients (75.4%), with 1-VD in 23.4%, 2-VD in 23.4%,
nd 3-VD in 28.5%, respectively. Staged procedures were
erformed in 78.6% of patients for CTO (39.4%) or
ultivessel disease (39.2%). Finally, complete revasculariza-
ion was achieved in 202 (59.9%) patients.
In total, 441 LM stents were implanted (56 BMS and
85 DES). Overall LM stent diameter and length were
.44  0.50 mm and 22.79  14.14 mm, respectively.
ngiographic LM success rate was 99.7%, significantly
igher than that of non-LM vessels (88.4%, p  0.022).
Table 3. Baseline Characteristics of Overall Patients
Indexes Values
Age, yrs 66.55 10.49
Men 266 (78.9)
AMI 85 (25.2)
STEMI 74 (21.9)
NSTEMI 11 (3.3)
Previous MI 46 (13.6)
Diabetes mellitus 85 (25.2)
Hypertension 238 (70.6)
Current smoker 121 (35.9)
Abnormal lipidemia 126 (37.4)
LVEF 40% 64 (19.0)
IABP 21 (6.2)
Temporary cardiac pacemaking 5 (1.5)
Emergency procedure for left main disease 22 (6.5)
Data are presented as n (%) or mean SD.
NSTEMI  non–ST-segment elevation myocardial infarction; STEMI  ST-segment elevationmyocardial infarction; other abbreviations as in Table 1.
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636ariables in NERS scoring system. The NERS score system
onsisted of 17 clinical, 4 procedural, and 33 angiographic
ariables (Tables 1 and 2). Of clinical variables, acute MI
ad the highest predicted score (7.3), followed by cardio-
enic shock (5.6), previous MI (5.5), and intra-aortic
Table 4. Angiographic and Procedural Characteristics
Indexes Values
Collaterals to LCA 169 (50.1)
Restenotic lesions 10 (3.0)
CTO
In LMT 8 (2.1)
In non-left main vessel 78 (23.1)
1 CTO lesion 64 (82.1)
2 CTO lesions 12 (17.9)
Location of lesions in LMT
Ostial 107 (31.8)
Body 102 (30.5)
Distal lesions 282 (83.7)
Whole stem 47 (13.9)
Nonbifurcation lesions 106 (31.5)
Bifurcation lesions 149 (44.2)
Trifurcation lesions 13 (4.6)
2-stent technique for distal left main lesions 122 (36.2)
DK crush 41 (33.6)
Classical crush 32 (26.2)
Culotte 21 (17.2)
T 20 (16.4)
V/SKS 8 (6.6)
Diseased vessels
Isolated left main 83 (24.6)
1 vessel 79 (23.4)
2 vessels 79 (23.4)
3 vessels 96 (28.5)
Complete revascularization 202 (59.9)
Stent number in left main 441
Per patient 1.31 0.47
Bare-metal stent 56 (12.69)
Drug-eluting stent 385 (87.31)
Stent diameter in left main, mm 3.44 0.50
Stent length in left main, mm 27.79 14.14
Overall stent number 1,089
Per-patient 3.23 0.74
Bare-metal stent 135 (12.40)
Drug-eluting stent 954 (87.60)
Overall stent diameter, mm 3.19 0.47
Overall stent length, mm 77.13 21.38
TIMI ﬂow grade 3 in left main pre-procedure 331 (98.2)
TIMI ﬂow grade 3 in non-LMT pre-procedure 238 (70.6)
Angiographic success in left main 336 (99.7)
Angiographic success in non-LMT 298 (88.4)
Data are presented as n (%), n, or mean SD.
TIMI Thrombolysis In Myocardial Infarction; other abbreviations as in Tables 1 and 2.alloon pump requirement (4.9). Of angiographic variables, homplex LM lesions, including distal stenosis, CTO, reste-
osis, severe calcification, and thrombotic lesions, had
igher predicted scores (5.9 to 10). Among procedural
ariables, failure of non–LM-CTO recanalization was as-
ociated with the highest predicted score (10.2), indepen-
ent of dominance. Conversely, predicted score of incom-
lete revascularization for right coronary or left circumflex
rteries was dependent on dominance. Importantly, logistic
egression analysis demonstrated that classical crush stent-
ng conferred higher predicted score (3.3), followed by SKS
2.6), and culotte (2.1), significantly different from that of
K crush and T-stenting (0.02 and 0.6, respectively) (p for
ll  0.001).
omparison of NERS versus SYNTAX score. The AUC
Figs. 1 and 2) was 0.89 for NERS score (95% CI: 0.86
o 0.93, p  0.001) and 0.69 for SYNTAX score (95% CI:
.63 to 0.76, p  0.001), when cumulative MACE was
onsidered as “state variable.” The absence of overlap of 95%
I between the 2 scoring systems, as well as larger AUC
p  0.0001), suggested that NERS score may be more
redictive of cumulative MACE. Similarly, there were
ignificant differences in AUC for cardiogenic death (0.86
s. 0.74, 95% CI: 0.79 to 0.94 vs. 0.54 to 0.75, p 0.0209),
I (0.78 vs. 0.55, 95% CI: 0.69 to 0.86 vs. 0.31 to 0.58,
 0.0316), TVR (0.84 vs. 0.68, 95% CI: 0.79 to 0.89 vs.
.59 to 0.76, p  0.0001) and ST (0.82 vs. 0.58, 95% CI:
.74 to 0.89 vs. 0.45 to 0.71, p  0.0007) between NERS
nd SYNTAX scores, respectively (Table 5).
omparisons of subgroups stratiﬁed by NERS and SYNTAX
cores. Per ROC curve, a value of 25 stratified scores as
ERS-lower (0 to 24) and NERS-higher (25). The
ERS-higher scores demonstrated enhanced MACE sen-
itivity and specificity of 92.0% and 74.1%, respectively
Table 6), which is significantly higher than those for
YNTAX-intermediate (20.5% and 25.4%, respectively, p
or all  0.001), SYNTAX-higher (70.5% and 35.2%,
espectively, p for all  0.001), and SYNTAX high-risk
90.9% and 32.4%, respectively, p for all 0.001) sub-
roups. Furthermore, a NERS-higher score surpassed
YNTAX score in prediction of ST, MI, LM-TVR, cardiac
eath, and cumulative MACE at follow-up; no differences
ere observed for in-hospital MACE and all-cause mortal-
ty at follow-up, however. Interestingly, the sensitivity and
pecificity for NERS-lower scores (8.0% and 3.7%) were
imilar to those of SYNTAX-lower (9.1% and 8.9%, p for
ll  0.05) scores.
By Kaplan-Meier analysis, in-hospital MACE-free sur-
ival differed significantly between NERS-lower (100%)
nd NERS-higher (89.1%, p  0.001) groups (Fig. 2A).
his difference was sustained throughout the entire follow-up
eriod (Fig. 2B). However, in-hospital (Fig. 2C) and
ollow-up (Fig. 2D) cumulative MACE were similar between
YNTAX-intermediate (90.0% and 72.0%) and SYNTAX-
igher (94.8% and 65.3%, p for all  0.05) subgroups.
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637Figure 1. Comparison of ROC Curve for NERS and SYNTAX Scores
The ﬁgures compare the receiver-operator characteristic (ROC) curves for NERS (New Risk Stratiﬁcation) and SYNTAX (Synergy between Percutaneous Coronary
Intervention with Taxus and Cardiac Surgery) scores for the following: (A) cumulative major adverse cardiac events (MACE), (B) stent thrombosis, (C) target ves-
sel revascularization (TVR) for left main trunk, (D) myocardial infarction, and (E) cardiac death at follow-up.
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638oreover, SYNTAX-lower individuals enjoyed improved sur-
ival with freedom from either in-hospital (100%, p  0.013)
r cumulative MACE at follow-up (91.4%, p  0.001), as
ompared to 2 other SYNTAX groups.
CA and clinical outcomes. Six-month angiographic
ollow-up (194 18 days post-procedure) was performed in
00 (89.0%) patients, with 100% 6-month clinical follow-
p. Rates of LM in-stent restenosis, target lesion revascu-
Figure 2. Comparison of Freedom From In-Hospital and Cumulative MACE S
Comparison of freedom from in-hospital (A) and overall major adverse cardiac
adverse cardiac events (D) survival among SYNTAX groups. Abbreviations as inarization, and -TVR were 12.2% (n  41), 9.8% (n  33), pnd 13.1% (n  44), respectively; with non-LM in-stent
estenosis, target lesion revascularization, and TVR rates of
6.9% (n  57), 15.5% (n  52), and 20.2% (n  68),
espectively. Not unexpectedly, in distal LM stenting, sig-
ificantly lower follow-up cumulative MACE rates were
bserved for single- versus double-stent techniques (20.4%
s. 32.5%, p  0.001).
linical outcomes. In-hospital follow-up was available for all
al Between NERS and SYNTAX Scores
s (B) survival between NERS groups, and in-hospital (C) and overall major
e 1.urviv
eventatients, with cumulative MACE rate of 4.7% (MI, TVR, and
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639ll-cause death in 4 [1.2%], 3 [0.9%], and 7 [2.1%] patients,
espectively), translating into 95.0% procedural success rate.
arly ST occurred in 6 patients (1.8%).
At average follow-up of 1,764 days, rates of MI, TVR,
nd cardiac mortality were 3.0%, 13.1%, and 5.6%, respec-
ively. Final cumulative MACE rate of 26.0% was driven
ainly by subsequent TVR. The overall ST rate was 6.0%
definite 3.6%, probable 1.0%, and possible 1.4%). By
egression analysis, NERS score 25 (hazard ratio: 1.13;
5% CI: 1.11 to 1.16; p  0.001) was the only independent
redictor of cumulative MACE and ST at follow-up (odds
atio: 31.04; 95% CI: 19.36 to 67.07; p  0.001).
iscussion
he present study yielded several notable findings: 1) when
ompared with SYNTAX score, NERS score demonstrated
nhanced sensitivity and specificity for prediction of cumu-
Table 5. ROC Analysis for NERS and SYNTAX Scores
NERS Score
Area 95% CI
In-hospital
Cardiogenic death 0.926 0.855–0.997
MI 0.871 0.733–0.958
TVR 0.688 0.574–0.801
Cumulative MACE 0.861 0.800–0.922
ST 0.847 0.726–0.967
At the follow-up
All-cause death 0.785 0.693–0.876
Cardiogenic death 0.864 0.793–0.935
MI 0.777 0.694–0.861
TVR 0.836 0.787–0.886
Cumulative MACE 0.891 0.857–0.926
ST 0.818 0.743–0.892
CI confidence interval; MACEmajor adverse cardiac event; ST st
in Table 1.
Table 6. Comparison of Diagnostic Values Between NERS and SYNTAX
Scoring System
SYNTAX Score
NERS Score
>33 23–32 >23 (>25) p Value*
Sensitivity 70.5 20.5 90.9† 92.0‡ 0.001
False-positive 64.6 74.6 67.6 25.9 0.001
Speciﬁcity 35.4 25.4 32.4 74.1 0.001
False-negative 29.5 79.5 9.1† 8.0 0.001
Values presented as %. *The p values indicate the comparison of NERS score versus SYNTAX
33 or SYNTAX 23 scores; †p  0.001 indicates the comparison of SYNTAX 23 versus
SYNTAX33 and 23 to 32 scores;‡p 0.05 indicates the comparisonofNERS25 scores versus
SYNTAX23 scores.hAbbreviations as in Table 1.ative MACE, ST, cardiogenic death, TVR, and MI;
) NERS-higher score had significantly greater predictive
alue over SYNTAX-intermediate, SYNTAX-higher, and
YNTAX-high-risk scores; 3) SYNTAX-intermediate and
YNTAX-higher scores demonstrated similar MACE pre-
ictability; and 4) SYNTAX-lower score had equivalent
redictive value to NERS-lower score.
lements of NERS score. Clinical, angiographic, and proce-
ural characteristics likely all contribute to prognosis after
PLMS stenting. However, quantification of each compo-
ent’s relative contribution is problematic, as there is little
upporting data from previous studies.
Findings indicative of decreased left ventricular ejection
raction and/or high-risk ischemic syndromes (including
cute MI, cardiogenic shock, previous MI, intra-aortic
alloon pump requirement), as well as complexity of lesion
orphologies and stenting techniques, have been associated
ith worse outcomes after stenting (4,12–22). Of note, for
ouble-stent techniques, in concurrence with previous re-
orts (3,4,9,10,23), DK-crush and T-stenting demonstrated
ower scores, as compared with classic crush, culotte, and
KS. This finding may be of interest for the practicing
nterventionalist.
omparison of NERS versus SYNTAX scores. We believe that
he augmented predictive accuracy of NERS over SYNTAX
core is reflective of the comprehensive inclusion of clinical,
ngiographic, and procedural features. The apparent lower
ensitivity and specificity of the SYNTAX score in the
resent study, as compared with the SYNTAX study, may
e partially ascribed to the study design. First, the SYN-
AX study did not provide the results of ROC for the
YNTAX score (20,24); moreover, repeat calculation might
SYNTAX Score
Value Area 95% CI p Value
0.000 0.775 0.612–0.937 0.013
0.011 0.617 0.360–0.875 0.419
0.091 0.665 0.539–0.786 0.188
0.000 0.635 0.503–0.768 0.067
0.004 0.541 0.327–0.755 0.732
0.000 0.707 0.598–0.817 0.001
0.000 0.742 0.543–0.752 0.000
0.003 0.545 0.305–0.583 0.545
0.000 0.675 0.592–0.759 0.000
0.000 0.695 0.632–0.758 0.000
0.000 0.580 0.447–0.712 0.232
mbosis; TVR target vessel revascularization; other abbreviations asp
ent throave included single lesions in the SYNTAX study. Impor-
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640antly, exclusion of clinical variables may be a potential
rawback of the SYNTAX score.
Cardiac risk factors and comorbid conditions were more
revalent in the PCI arm of SYNTAX (14). Whereas such
linical variables are known to influence the prognosis of
atients with UPLMS (3,4,7,8,18–24), their relative con-
ributions were omitted from the SYNTAX score. Our
ndings underscore the potential importance of the inter-
lay of clinical, procedural, as well as angiographic variables.
ubgroup analysis stratiﬁed by NERS and SYNTAX scores.
he SYNTAX-lower scores had equivalent predictive value
o NERS-lower scores (less complex lesions, fewer comor-
id conditions and cardiac risk factors, and simple stenting
echniques), with fewer associated follow-up events. In
ontrast to the original SYNTAX trial, our data revealed
imilar sensitivity and specificity between SYNTAX-
ntermediate and SYNTAX-higher groups. Of note, the
redictive value of NERS-higher in the present study has
reater predictive value over SYNTAX high-risk groups.
his observation likely again reflects the cumulative contri-
ution of clinical and angiographic/procedural features.
tudy limitations. First, its nonrandomized nature likely
nfluences the power of the results. Second, both BMS and
ES were included. Although no score was generated for
MS patients, their inclusion influences the relevance of our
esults to modern practice. Moreover, comparison of non-
CA baseline angiography (reflective of the “real world”)
ith follow-up QCA undoubtedly influenced luminal mea-
urements. Without randomization, operator selection of
he specific 2-stent technique likely reflects lesion complex-
ty, thereby influencing outcome. Additionally, the NERS
core was derived from a relatively small number of patients
ndergoing PCI in 4 centers in 1 country. Clearly, its
pplicability to other demographics requires further study.
onclusions
he NERS score demonstrated improved predictive value
or primary end points after UPLMS-PCI, as compared
ith SYNTAX score. Further, randomized studies are
eeded to elucidate its role for decision of PCI versus
ABG for UPLMS and complex anatomies in a more
iverse population.
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